A celebration of innovation in UK pharma.
The pharma industry is the single biggest source of global R&D. It already accounts for 48% of national R&D spend in the UK. Other than the US, Britain has developed more medicines than any other country. Prix Galien rewards that investment in innovation. Click on the video to find out why.
Best Pharmaceutical Product
The UK Prix Galien Award for Best Pharmaceutical Product is open to any medicine that has been developed to prevent, cure and/or treat disease that has had a significant, positive impact on improving patient lives.
Eligibility criteria:
Products must have received marketing approval between December 31, 2018 – December 31, 2023 (unless the award is for a new/innovative indication added during that period)
We accept nominations for individual products, not classes of products. We assume that nominees possess permission of the current owner(s) of the product rights.
- See Quick Facts Sheet
The awards have a global impact and a global reputation.
